Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | ICMT | O60725 | 14/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | FNTA | P49354 | 1/20 | 0.56 |
| ▸ | FNTB | P49356 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5423426 | 1.00 | MAPT (1.00) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL8025173 | 1.00 | MAPT (1.00) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL2818645 | 1.00 | MAPT (1.00) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL5433147 | 1.00 | MAPT (1.00) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL664393 | 1.00 | MAPT (1.00) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL5274733 | 1.00 | MAPT (1.00) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL1648111 | 1.00 | MAPT (1.00) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL4024890 | 1.00 | MAPT (1.00) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL1648108 | 1.00 | MAPT (1.00) | MAPTALDH1A1ICMTMEN1TRPA1 | |
| SCHEMBL1762100 | 0.99 | MAPT (0.97) | MAPTALDH1A1ICMTMEN1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036245-B2 | Pharmaceutical composition and cosmetic composition | I PEACE, INC. (US) | 2024-07-16 | — | — | US | claimed |
| US-20240099944-A1 | Stable Skin Care Compositions Containing a Retinoid | THE PROCTER & GAMBLE COMPANY | 2024-03-28 | — | — | US | claimed |
| US-20170157170-A1 | COMPOSITIONS CONTAINING POLYMERIC SULFUR AND USES THEREOF | KENVUE BRANDS LLC | 2017-06-08 | — | — | US | claimed |
| EP-3175888-A1 | COMPOSITIONS CONTAINING POLYMERIC SULFUR AND USES THEREOF | Johnson & Johnson Consumer Inc. (US) | 2017-06-07 | — | — | EP | claimed |
| US-20260057182-A1 | Graphics-Informed Data-Contextual Report Compilation via Automated Point-of-Interest Detection in Visualization Inventories | PONTIMYX CORP (US) | 2026-02-26 | — | — | US | disclosed |
| US-20250339471-A1 | PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION | I PEACE, INC. (US) | 2025-11-06 | — | — | US | disclosed |
| US-12456017-B2 | Interactive neural-symbolic orchestration of subjective stored procedures | PONTIMYX CORP (US) | 2025-10-28 | — | — | US | disclosed |
| US-20250302710-A1 | SKIN CARE COMPOSITIONS CONTAINING A RETINOID WITH REDUCED MALODOR | THE PROCTER & GAMBLE COMPANY | 2025-10-02 | — | — | US | disclosed |
| US-12383583-B2 | Pharmaceutical composition and cosmetic composition | I PEACE, INC. (US) | 2025-08-12 | — | — | US | disclosed |
| US-20250165717-A1 | Multilevel Data Analysis | PONTIMYX CORP (US) | 2025-05-22 | — | — | US | disclosed |
| US-12210839-B1 | Multilevel data analysis | Pontimyx Corporation | 2025-01-28 | — | — | US | disclosed |
| US-20240316117-A1 | PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITION | I PEACE, INC. (US) | 2024-09-26 | — | — | US | disclosed |
| US-20030228688-A1 | Antisense modulation of isoprenylcysteine carboxyl methyltransferase expression | ISIS PHARMACEUTICALS INC. | 2003-12-11 | — | — | US | disclosed |
| US-6432403-B1 | INHIBITORS OF CARBOXYL METHYLATION IN TREATMENT OF INFLAMMATION AND CANCER; SPECIFIC FOR AN EPITOPE OF THE PROTEIN CONSISTING OF THE AMINO ACID SEQUENCE OF SEQ ID NO:5 | NEW YORK UNIVERSITY | 2002-08-13 | — | — | US | disclosed |
| US-6232108-B1 | RECOMBINANT DNA CODING FOR ENZYME OF DEFINED AMINO ACID SEQUENCE WHICH IS INVOLVED IN FURTHER POST-TRANSLATIONAL PROCESSING OF PRENYLATED PROTEINS; DRUG SCREENING OF ANTICARCINOGENIC AND ANTINFLAMMATORY AGENTS | NEW YORK UNIVERSITY | 2001-05-15 | — | — | US | disclosed |
| US-6184016-B1 | AMINO ACID SEQUENCE OF ENZYME INVOLVED IN POST-TRANSLATIONAL MODIFICATION OF PRENYLATED PROTEINS; FOR SCREENING OF ENZYME INHIBITORS; ANTIINFLAMMATORY/ANTICARCINOGENIC AGENTS | NEW YORK UNIVERSITY | 2001-02-06 | — | — | US | disclosed |
| US-6015877-A | ANTICARCINOGENIC AGENT WHICH INHIBITS ENDOPROTEASE ACTIVITY DIRECTED AGAINST SPECIFIC CYSTEINE CONTAINING CARBOXY TERMINAL MOTIF FOUND IN RAS PROTEINS AND OTHER SIGNAL TRANSDUCING G PROTEINS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-01-18 | — | — | US | disclosed |
| US-5789541-A | ENZYME INHIBITORS, FARNESYL OR GERANYL GROUPS, CONTROLLING NEOPLASTIC CELL GROWTH, ANTITUMOR, ANTICARCINOGENIC AGENTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-08-04 | — | — | US | disclosed |
| US-5202456-A | Anticarcinogenic agents; methylating transferase inhibitors; farnesyl or geranyl sulfur-, oxygen or selenium-containing derivatives | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1993-04-13 | — | — | US | disclosed |
| WO-1992018465-A2 | COMPOUNDS FOR INHIBITION OF PROTEIN METHYLATION | THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1992-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260057182-A1 | Graphics-Informed Data-Contextual Report Compilation via Automated Point-of-Interest Detection in Visualization Inventories | NOTCH1, NOTCH4, DNER | MAPT 720/4885ALDH1A1 4058/4885ICMT 3118/4885 |
| US-20250302710-A1 | SKIN CARE COMPOSITIONS CONTAINING A RETINOID WITH REDUCED MALODOR | RBP4, RARA, RBP1 | MAPT 1006/4885ALDH1A1 20/4885ICMT 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.